Tricuspid Valve Replacement Using the Right Atrial Appendage Valve: Techniques and 1-Year Results
Authors:
- Ahmad Ali AmirghofranAAAhmad Ali Amirghofran
- Seyed Alireza MirhosseiniSMSeyed Alireza Mirhosseini
- Roozbeh Narimani-JavidRNRoozbeh Narimani-Javid
- Mohammad Reza EdrakiMEMohammad Reza Edraki
- Mohammad Rafati NavaeiMNMohammad Rafati Navaei
- Hamid MohammadiHMHamid Mohammadi
- Soorena KhorshidiSKSoorena Khorshidi
- Salma NozhatSNSalma Nozhat
- Zahra Savand RoomiZRZahra Savand Roomi
- Hamed Bazrafshan DrissHDHamed Bazrafshan Driss
- Sasan ShafieiSSSasan Shafiei
- Alireza ArzhangzadehAAAlireza Arzhangzadeh
Open Access
- 15 September 2025
- journal article
- research article
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (10)
Abstract
Objectives: When tricuspid valve repair is unfeasible due to extensive damage or a complex congenital malformation, surgeons consider tricuspid valve replacement (TVR). However, it is still controversial and challenging to choose the best substitute. We aimed to introduce the innovative intraoperatively valve construction using the native right atrial appendage (RAA) tissue for TVR and investigate the short-term outcomes. Methods: This study recruited paediatric and adult patients with unrepairable severe tricuspid regurgitation (TR) who needed TVR. The patient’s RAA tissue was harvested and used to reconstruct a native bileaflet valve during surgery. Transthoracic echocardiography was conducted before operation, 6, and 12 months after surgery. Results: The procedure was successfully executed on 3 patients with valve destruction as a result of infective endocarditis, and 3 patients who had severe TR due to congenital anomalies. There was no mortality or related morbidity. All the constructed valves had proper function with no complications after the surgery. Follow-up echocardiographic studies showed stable and satisfactory valve function with no regurgitation or significant stenosis. Conclusions: The novel tricuspid valve operation using native RAA tissue demonstrates promising short-term results. Further studies with larger cohorts and longer follow-ups are required to confirm the technique’s reliability and long-term effectiveness.Keywords
This publication has 24 references indexed in Scilit:
- Contemporary Etiologies, Outcomes, and Novel Risk Score for Isolated Tricuspid RegurgitationJACC: Cardiovascular Imaging, 2022
- Surgical treatment of right-sided infective endocarditisThe Journal of Thoracic and Cardiovascular Surgery, 2019
- Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2019
- Improving Results of Surgery for Ebstein Anomaly: Where Are We After 235 Cone Repairs?The Annals of Thoracic Surgery, 2018
- Propensity Score Matching Analysis of Mechanical Versus Bioprosthetic Tricuspid Valve ReplacementsThe Annals of Thoracic Surgery, 2014
- Trends and Outcomes of Tricuspid Valve Surgery in North America: An Analysis of More Than 50,000 Patients From The Society of Thoracic Surgeons DatabaseThe Annals of Thoracic Surgery, 2013
- The Growing Clinical Importance of Secondary Tricuspid RegurgitationJACC, 2012
- Midterm Follow-Up of Tricuspid Valve Reconstruction Due to Active Infective EndocarditisThe Annals of Thoracic Surgery, 2007
- The cone reconstruction of the tricuspid valve in Ebstein’s anomaly. The operation: early and midterm resultsThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Impact of tricuspid regurgitation on long-term survivalJACC, 2004